A major step towards launching a booster campaign to combat the newest members of the omicron family was taken by Pfizer on Monday when they asked US regulators to approve their combination COVID-19 vaccine. The Food and Drug Administration has
Trending
- New Global Initiative Seeks to Modernize Health Workforce Mobility
- Younger women face breast cancer risk in Africa, SGU warns
- Sheikh Khaled begins official visit to Greece in Athens
- South Korea chip exports surge 222.5% in early October
- Ultrasonic welding method doubles strength of metal joints
- Türkiye aims to rank sixth in global tourism revenue
- JAXA MMX mission lifts off for Mars moon Phobos
- Abdullah bin Zayed and Jaishankar discuss UAE-India ties
